Author details

Full Name

Jean Pelletier

Affiliation

ORCID

Career Start Year

1990

Papers

231

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37351881	Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis.		2023
36376096	Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study.	Neurology: Neuroimmunology and NeuroInflammation	2023
36426377	Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study.	Lancet Regional Health - Europe, The	2023
37604695	Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?		2023
37827849	Comparison of Two Methods for Estimating MS-Related Mortality: The Excess Mortality vs. the Cause-Specific Frameworks.		2023
37562829	Contribution of the MP2RAGE 7T Sequence in MS Lesions of the Cervical Spinal Cord.		2023
37550074	Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before Conception.		2023
36515394	Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system.		2023
37015059	Validation of ELISA assays for the calculation of FLC indices for the diagnosis of intrathecal immunoglobulin synthesis.		2023
37453261	The biological sample collection of the OFSEP French MS registry: An essential tool dedicated to researchers.		2023
36564207	Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference.		2023
34931885	Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis optica.	Multiple Sclerosis Journal	2022
35637426	Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.	BMC Medical Research Methodology	2022
35497647	A Case of Childhood Severe Paroxysmal Cold Hemoglobinuria with Acute Renal Failure Successfully Treated with Plasma Exchange and Eculizumab.		2022
35473885	Pure Relapsing Short Myelitis: Part of the Multiple Sclerosis Spectrum or New Entity?	Neurology: Neuroimmunology and NeuroInflammation	2022
35723278	Grey-matter sodium concentration as an individual marker of multiple sclerosis severity.	Multiple Sclerosis Journal	2022
35977837	Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.	Neurology	2022
37465134	Use of An Ophthalmology Tutorial to Improve Resident Comfort with the Emergency Eye Exam.		2022
34462791	Decrease in the cortex/striatum metabolic ratio on [F]-FDG PET: a biomarker of autoimmune encephalitis.	European Journal of Nuclear Medicine and Molecular Imaging	2022
35217934	Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal.		2022
35115188	Necrotizing Soft Tissue Infections (NSTI): Pearls and Pitfalls for the Emergency Clinician.	Journal of Emergency Medicine	2022
34815322	Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab.	Neurology: Neuroimmunology and NeuroInflammation	2022
34536228	Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts.	CNS Drugs	2021
32202216	Maintenance of natalizumab during the first trimester of pregnancy in active multiple sclerosis.	Multiple Sclerosis Journal	2021
32180508	Comparison of rituximab originator (MabThera) to biosimilar (Truxima) in patients with multiple sclerosis.	Multiple Sclerosis Journal	2021
34240579	DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France.	Annals of Clinical and Translational Neurology	2021
33903203	Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab.	Neurology: Neuroimmunology and NeuroInflammation	2021
34116480	The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies.	Multiple Sclerosis and Related Disorders	2021
34007368	Severe Cystic Echinococcosis-Associated Immune Thrombocytopenic Purpura: A Case Report.		2021
34103339	TNF-Î± inhibitors used as steroid-sparing maintenance monotherapy in parenchymal CNS sarcoidosis.	Journal of Neurology, Neurosurgery and Psychiatry	2021
33722933	Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody-Associated Diseases.	Neurology: Neuroimmunology and NeuroInflammation	2021
34193589	Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple Sclerosis.	Neurology	2021
33650261	Untreated patients with multiple sclerosis: A study of French expert centers.	European Journal of Neurology	2021
32584194	Fatal underhanded chronic enterovirus infection associated with anti-CD20 monotherapy for central nervous system demyelinating disease.	Multiple Sclerosis Journal	2021
32964402	Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis.		2021
33340929	First line treatment failure: Predictive factors in a cohort of 863 Relapsing Remitting MS patients.	Multiple Sclerosis and Related Disorders	2021
32852445	T1-Based Synthetic Magnetic Resonance Contrasts Improve Multiple Sclerosis and Focal Epilepsy Imaging at 7 T.	Investigative Radiology	2021
33326668	Assessing the experience of the quality of care of patients living with multiple sclerosis and their caregivers: The MusiCare questionnaire.	European Journal of Neurology	2021
33269975	Oral nomegestrol acetate and transdermal 17-beta-estradiol for preventing post-partum relapses in multiple sclerosis: The POPARTMUS study.	Multiple Sclerosis Journal	2021
33423618	Determinants of therapeutic lag in multiple sclerosis.	Multiple Sclerosis Journal	2021
34925877	Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapy.	Multiple Sclerosis Journal - Experimental, Translational and Clinical	2021
30480467	Longitudinal study of functional brain network reorganization in clinically isolated syndrome.	Multiple Sclerosis Journal	2020
32248045	Effect of hyperglycemia on stroke outcome is not homogeneous to all patients treated with mechanical thrombectomy.	Clinical Neurology and Neurosurgery	2020
32414903	Sensitivity of the Inhomogeneous Magnetization Transfer Imaging Technique to Spinal Cord Damage in Multiple Sclerosis.		2020
31725931	Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibody Diseases.	Annals of Neurology	2020
32439640	Improved Cervical Cord Lesion Detection with 3D-MP2RAGE Sequence in Patients with Multiple Sclerosis.		2020
32587103	Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond?	Neurology: Neuroimmunology and NeuroInflammation	2020
32572488	Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disability.	Brain	2020
30541380	Observatoire FranÃ§ais de la SclÃ©rose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France.	Multiple Sclerosis Journal	2020
31439633	Prospective validation of the PML risk biomarker l-selectin and influence of natalizumab extended intervals.	Neurology	2019